Jubilant Ingrevia commissions new Diketene derivatives facility at Gajraula

17 Feb 2022 Evaluate

Jubilant Ingrevia has commissioned new Diketene derivatives facility at its manufacturing site in North India at Gajraula, Uttar Pradesh. The company for many years has niche expertise in using Ketene chemistry technology. Using the Ketene chemistry capability, the company has developed a range of Diketene Derivatives. The newly commissioned facility marks the entry of the company into the fast growing Diketene business portfolio. This reiterates Jubilant Ingrevia’a commitment towards growth through its integrated business model, by providing value added products & innovative solutions to its customers.

The commissioned facility has about 7,000 TPA capacity to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate and Ter-Butyl Acetoacetate). The Company’s long-standing association with leading customers in Pharmaceuticals, Agrochemicals and other industries and its advance efforts to get product approval from customers, will help in utilizing a major portion of the capacity of this new facility in the coming months. Jubilant Ingrevia undertakes to commission future phases of Diketene Derivatives as per plan.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Jubilant Ingrevia Share Price

711.50 1.15 (0.16%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3897.70
Tata Chemicals 763.85
SRF 3102.70
Pidilite Inds. 1458.40
Deepak Nitrite 1765.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×